Cipher Pharmaceuticals Inc
TSX:CPH
Wall Street
Price Targets
CPH Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for CPH is 11.81 CAD with a low forecast of 8.08 CAD and a high forecast of 22.05 CAD.
Operating Income
Forecast
Operating Income Estimate
Cipher Pharmaceuticals Inc
For the last 8 years the compound annual growth rate for Cipher Pharmaceuticals Inc's operating income is 24%. The projected CAGR for the next 5 years is -10%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CPH's stock price target?
Price Target
11.81
CAD
According to Wall Street analysts, the average 1-year price target for CPH is 11.81 CAD with a low forecast of 8.08 CAD and a high forecast of 22.05 CAD.
What is Cipher Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
1%
For the last 8 years the compound annual growth rate for Cipher Pharmaceuticals Inc's revenue is -6%. The projected CAGR for the next 3 years is 1%.
What is Cipher Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-10%
For the last 8 years the compound annual growth rate for Cipher Pharmaceuticals Inc's operating income is 24%. The projected CAGR for the next 5 years is -10%.
What is Cipher Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
-26%
For the last 8 years the compound annual growth rate for Cipher Pharmaceuticals Inc's net income is 36%. The projected CAGR for the next 3 years is -26%.